Literature DB >> 8457508

Ophthalmic findings in classical galactosaemia--prospective study.

B Beigi1, M O'Keefe, R Bowell, E Naughten, N Badawi, B Lanigan.   

Abstract

Thirty three children with classical galactosaemia diagnosed through newborn screening are considered. It is concluded that cataract formation has a direct relationship with poor dietary control. Erythrocyte galactose-1-phosphate (Gal-1-P) levels do not correspond to cataract formation unless many times higher than normal. The value of crystalline lens biomicroscopy is confirmed as a useful method for monitoring the dietary and biochemical control in classical galactosaemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8457508      PMCID: PMC504462          DOI: 10.1136/bjo.77.3.162

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  12 in total

1.  Galactosemia, a congenital defect in a nucleotide transferase.

Authors:  H M KALCKAR; E P ANDERSON; K J ISSELBACHER
Journal:  Biochim Biophys Acta       Date:  1956-04

2.  Deficit of uridine diphosphate galactose in galactosaemia.

Authors:  W G Ng; Y K Xu; F R Kaufman; G N Donnell
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

3.  A simple spot screening test for galactosemia.

Authors:  E Beutler; M C Baluda
Journal:  J Lab Clin Med       Date:  1966-07

4.  Cataracts in children with classical galactosaemia and in their parents.

Authors:  J P Burke; M O'Keefe; R Bowell; E R Naughten
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

Review 5.  Galactose and cataract.

Authors:  D Stambolian
Journal:  Surv Ophthalmol       Date:  1988 Mar-Apr       Impact factor: 6.048

6.  Metabolic studies of galactosemic cataract.

Authors:  H M Cheng; H Xiong; J Xiong; K Tsubota
Journal:  Exp Eye Res       Date:  1990-10       Impact factor: 3.467

7.  Idiopathic presenile cataract formation and galactosaemia.

Authors:  R E Stevens; M B Datiles; S K Srivastava; N H Ansari; A E Maumenee; W J Stark
Journal:  Br J Ophthalmol       Date:  1989-01       Impact factor: 4.638

Review 8.  Galactose disorders: an overview.

Authors:  J B Holton
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

9.  Curious neurologic sequelae in galactosemia.

Authors:  W Lo; S Packman; S Nash; K Schmidt; S Ireland; I Diamond; W Ng; G Donnell
Journal:  Pediatrics       Date:  1984-03       Impact factor: 7.124

10.  Ophthalmic findings in classical galactosemia--a screened population.

Authors:  J P Burke; M O'Keefe; R Bowell; E R Naughten
Journal:  J Pediatr Ophthalmol Strabismus       Date:  1989 Jul-Aug       Impact factor: 1.402

View more
  6 in total

Review 1.  Appropriateness of newborn screening for classic galactosaemia: a systematic review.

Authors:  L Varela-Lema; L Paz-Valinas; G Atienza-Merino; R Zubizarreta-Alberdi; R Vizoso Villares; M López-García
Journal:  J Inherit Metab Dis       Date:  2016-04-26       Impact factor: 4.982

2.  Biochemical monitoring of treatment for galactosaemia: biological variability in metabolite concentrations.

Authors:  A C Hutchesson; C Murdoch-Davis; A Green; M A Preece; J Allen; J B Holton; G Rylance
Journal:  J Inherit Metab Dis       Date:  1999-04       Impact factor: 4.982

3.  Diet and visually significant cataracts in galactosaemia: is regular follow up necessary?

Authors:  John Widger; Jennifer O'Toole; Olivia Geoghegan; Micheal O'Keefe; Rosemarie Manning
Journal:  J Inherit Metab Dis       Date:  2010-02-12       Impact factor: 4.982

Review 4.  The role of polyols in the pathophysiology of hypergalactosemia.

Authors:  G T Berry
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

Review 5.  Pediatric cataract: challenges and future directions.

Authors:  Anagha Medsinge; Ken K Nischal
Journal:  Clin Ophthalmol       Date:  2015-01-07

Review 6.  Diagnosing the oil drop: A case report and review of the literature.

Authors:  Riddhi J Chhapan; Revathi Yerramneni; Muralidhar Ramappa
Journal:  Indian J Ophthalmol       Date:  2019-10       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.